MAO-B INHIBITORS AND QUINOLONES
Ciprofloxacin increases the AUC of rasagiline by 83%.
The clinical relevance of this pharmacokinetic interaction has not been assessed. The manufacturers suggest that caution is warranted on concurrent use. Other quinolones may also interact, see quinolones.
The clinical relevance of this pharmacokinetic interaction has not been assessed. The manufacturers suggest that caution is warranted on concurrent use. Other quinolones may also interact, see quinolones.